RxDoctor Payments Data

Natalie Frost, APRN

Gerontology · Minneapolis, MNNPI 1407479231

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $396, 2.4 times the $167 reported in 2022.

$925in general payments, 2019–2025

Across 46 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$101
  • Edwards Lifesciences$79
  • Amgen$72
  • Pfizer$71
  • Novartis$70
  • E.r. Squibb & Sons, L.L.C.$69
  • plus $464 from 15 others

What the payments were for

  • Food & beverage$925100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$925 in reported general payments places this provider in the 85th percentile of 106 gerontology providers in Minnesota.

See all gerontology providers in Minnesota

Medicare billing

Part B allowed, 2024
$9,559
Medicare patients
104
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin16$20,099
BrilintaTicagrelor28$20,057
EliquisApixaban15$14,399
ClopidogrelClopidogrel Bisulfate106$1,784
Rosuvastatin Calcium66$887
Metoprolol Succinate33$686
Nitroglycerin61$509
Carvedilol32$373
Losartan Potassium36$338
Spironolactone36$304
Atorvastatin Calcium11$214
Isosorbide Mononitrate ErIsosorbide Mononitrate13$149
Furosemide23$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$23$20,09916 claims
PfizerEliquis$71$14,39915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 106 gerontology providers in Minnesota.

Other gerontology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →